Irish clinical trials company Icon gets €4m in State funding

Dublin-founded, Nasdaq-listed group employs more than 1,000 people in State

The R&D support will help in the development of tech-enabled systems that provide greater flexibility and reduce the burden felt by clinical trial participants.

The R&D support will help in the development of tech-enabled systems that provide greater flexibility and reduce the burden felt by clinical trial participants.

Nasdaq-listed clinical trials group Icon has been awarded €4 million in R&D supports by the Irish Government.

The Dublin-founded company, which employs more than 1,000 people in the Republic, is to use the funding to expand patient access to clinical research through the use of technology.

Please subscribe or sign in to continue reading.
only €1 first month

Insightful opinion is just a away.